Omar, M., ELBassiouny, O., EL-Nahass, H., Radwan, T., Elgharib, M. (2024). Age-related Neovascularization Response to Intravitreal Anti-vascular Endothelial Growth Factor. Suez Canal University Medical Journal, 27(1), 73-82. doi: 10.21608/scumj.2024.342793
Mohamed S. Omar; Osama M. ELBassiouny; Hussein S. EL-Nahass; Tarak M. Radwan; Mervet E. Elgharib. "Age-related Neovascularization Response to Intravitreal Anti-vascular Endothelial Growth Factor". Suez Canal University Medical Journal, 27, 1, 2024, 73-82. doi: 10.21608/scumj.2024.342793
Omar, M., ELBassiouny, O., EL-Nahass, H., Radwan, T., Elgharib, M. (2024). 'Age-related Neovascularization Response to Intravitreal Anti-vascular Endothelial Growth Factor', Suez Canal University Medical Journal, 27(1), pp. 73-82. doi: 10.21608/scumj.2024.342793
Omar, M., ELBassiouny, O., EL-Nahass, H., Radwan, T., Elgharib, M. Age-related Neovascularization Response to Intravitreal Anti-vascular Endothelial Growth Factor. Suez Canal University Medical Journal, 2024; 27(1): 73-82. doi: 10.21608/scumj.2024.342793
Age-related Neovascularization Response to Intravitreal Anti-vascular Endothelial Growth Factor
Department of Ophthalmology, Faculty of Medicine, Suez Canal University, Egypt
Abstract
Background: A medical disorder called age-related macular degeneration (AMD) can cause impaired or absent vision in the center of the visual field. Initially, there are frequently no symptoms. A non-invasive imaging method called Spectral Domain Optical Coherence Tomography (SD-OCT) can show structural alterations in the retinal pigment epithelium (RPE) and neurosensory retina. Anti-vascular endothelial growth factor Anti-VEGF is often administered intravitreally to slow or stop the formation of blood vessels by blocking its interaction with receptors on the surface of endothelial cells. Aim: To describe changes in age-related choroidal neovascularization CNV to intravitreal anti-VEGF using OCTA. Methods: We conducted a prospective quasi-experimental study on 30 eyes of patients with neovascular AMD at the Suez Canal University Hospital's Ophthalmic Outpatient Clinic to observe how CNV responded to anti-VEGF for improved visual results and more effective follow-up in this patient group. Results: There was a highly statistically significant difference between different periods regarding both CNV area (p < 0.001), and CNV fine vessel density (p < 0.001). Conclusion: OCT-A is a quick, non-invasive, and repeatable way to examine exudative AMD. It offers precise data on the region of the CNV that responds to anti-VEGF treatment, and it is a promising imaging technique that permits assessment of the CNV fine vascular density response to anti-VEGF.
View on SCiNiTO
Top